SlideShare a Scribd company logo
1 of 5
Download to read offline
Biotech and medtech consultants for venture
                                                                   funds, industry and tech transfer offices.




Services

1. CONSULTING

  Product or Technology Assessment
  Comprehensive assessment of all aspects concerning the business opportunity of your biotech or medtech
  technology. We partner with key experts in each field, and provide a range of services for your project analysis:
  1.a. Draft Assessment.            1.b. Product viability.                   1.c. Business Plan.
  A 2-week qualitative              A 2-month complete assessment             A 4-month complete assessment
  assessment interviewing key       with secondary data, interviewing         involving field experts, primary
  internal researchers. The         key internal researchers, and a           market research of key players
  basic check for early stage       thorough analysis of publicly             and KOLs, providing a full road
  technologies.                     available information. The must-          map and business plan. The basis
                                    have for preparing spin-outs and          for raising significant venture
                                    obtaining seed funding.                   funding.


  Lifescience Corporate Strategy
  Also, if you are an established corporation and want to enter the biotech and medtech sectors, or improve your
  current position, we can assist you in developing the best strategy that fits your company capabilities.




2. FINANCING

  Venture Fund Strategy
  If you want to create a successful venture fund in the lifescience arena, we help you designing the strategy and
  connecting you with national and international strategic investors. We have worked successfully with tech
  transfer funds, accelerator funds and later-stage venture funds.

  Start-up Fund Raising
  If your product or technology has been successfully analyzed by us, we can assist you in obtaining public and
  private funding, connecting you with a broad investors’ network and coaching you during the process.




3. INTERIM MANAGEMENT

  If you are a start-up or want to spin-out a company in the biotech and medtech sectors, we can act as interim
  CEO and implement an early strategy until consolidation. Your opportunity to access experienced management in
  a capital efficient and flexible way to get your business off the ground.
Biotech and medtech consultants for venture
                                                                       funds, industry and tech transfer offices.




Track Record

Truly international. Working experience based in the USA, Germany, the UK and Spain, with a truly international
approach. Managed multinational teams of experts.

Real world experience. Lead launch strategy for multiple new products globally. Integrate technology, IP, clinical
development, CMC, regulatory, PRA & marketing.

Business Development. Closed licensing deals of up to $300mn. Out-licensing and in-licensing experience.
Pipeline prioritization. Target product profiling, valuation and risk assessment.

Consulting expertise. More than 30 products analyzed to date in biotech and medtech, for multinationals,
startups and tech transfer offices. Focus on disruptive innovation technologies.

Broad professional network. Broad national and international network of investors and professionals in the
sector. Raised over €30 million in venture capital in the past.




Partnerships



                                              We are the lifescience advisors for the IESE Business
                                              Angels & Family Office Network.



                                              We have an exclusivity agreement with ONE to ONE as
                                              Lifescience Industry Experts with access to all their
                                              corporate finance expertise.



                                              We act as business advisors for m+vision, the
                                              consortium between the MIT and the Madrid Region
                                              to support joint innovation in medical devices.



                                              We collaborate with TTS Ltd in creating and developing
                                              outstanding international tech transfer events, like the
                                              TTS Biomedtech 2013.



                                              We are members of the Biospain’s Investment Jury, to
                                              help them evaluate new biomedical technologies.
Biotech and medtech consultants for venture
                                                                      funds, industry and tech transfer offices.




Examples of technologies analyzed to date


       Pharma/Biotech                          Advanced Therapies                             Medical Devices

PDE5 inhibitor for treatment of          Dendritic cell autologous                    Multiparametric microchip for
pulmonary arterial                       vaccines loaded with tumor                   detection of biofilms in
hypertension.                            antigen for cancer treatment.                implanted catheters.

Estrogen receptor β for                  Cultured autologous                          Impedimetric sensor device for
treatment of BPH.                        melanocytes on a nanofiber                   endotoxin detection.
                                         scaffold for vitiligo treatment.
ADP receptor inhibitor for                                                            Flat electrode arrays for
treatment of acute coronary              Biodegradable nanofiber                      cochlear implant atraumatic
syndrome.                                polymer for direct                           surgery.
                                         chemotherapy delivery in
PDE5 inhibitor for treatment of          glioblastoma treatment .                     Interactive real-time platform
benign prostatic hyperplasia.                                                         for biological soft tissue
                                         LSCD corneal regeneration with               mechanical behaviour
RNA‐sequencing biomarkers for                                                         simulation.
                                         limbal tissue cultured on
cancer diagnosis and prognosis.
                                         polymeric scaffolds.
                                                                                      Magnetic resonance
DNA marker-based kit to predict          Biodegradable drug eluting                   elastography system to improve
rectal cancer response to                stents with nanofiber polymers.              brain imaging.
neoadjuvant RCT.
                                                                                      Robotic computer assisted
                                         Wound healing nanofiber
PDE5 inhibitor for treatment of                                                       surgery for transpedicular spine
                                         bandages with drug delivery
Peyronie’s disease.                                                                   fixation.
                                         technology.




WRAPUP©. Our proprietary product assessment approach

                                                    Relevant
                                  Is there a real unmet need for your tech today?



                              Profitable                                    Unique
       How profitable and cashable is it?                                   Will it stay competitive in the future?
                                                      What




                                     Achievable                   Protectable
     What risks & barriers may prevent success?                   Can it be protected from copyists?
www.dynomicsbmt.com   Now follow us at:

More Related Content

Featured

How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
ThinkNow
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Kurio // The Social Media Age(ncy)
 

Featured (20)

2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot
 
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTEverything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPT
 
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsProduct Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage Engineerings
 
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
 
Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 

Dynomics consulting services

  • 1.
  • 2. Biotech and medtech consultants for venture funds, industry and tech transfer offices. Services 1. CONSULTING Product or Technology Assessment Comprehensive assessment of all aspects concerning the business opportunity of your biotech or medtech technology. We partner with key experts in each field, and provide a range of services for your project analysis: 1.a. Draft Assessment. 1.b. Product viability. 1.c. Business Plan. A 2-week qualitative A 2-month complete assessment A 4-month complete assessment assessment interviewing key with secondary data, interviewing involving field experts, primary internal researchers. The key internal researchers, and a market research of key players basic check for early stage thorough analysis of publicly and KOLs, providing a full road technologies. available information. The must- map and business plan. The basis have for preparing spin-outs and for raising significant venture obtaining seed funding. funding. Lifescience Corporate Strategy Also, if you are an established corporation and want to enter the biotech and medtech sectors, or improve your current position, we can assist you in developing the best strategy that fits your company capabilities. 2. FINANCING Venture Fund Strategy If you want to create a successful venture fund in the lifescience arena, we help you designing the strategy and connecting you with national and international strategic investors. We have worked successfully with tech transfer funds, accelerator funds and later-stage venture funds. Start-up Fund Raising If your product or technology has been successfully analyzed by us, we can assist you in obtaining public and private funding, connecting you with a broad investors’ network and coaching you during the process. 3. INTERIM MANAGEMENT If you are a start-up or want to spin-out a company in the biotech and medtech sectors, we can act as interim CEO and implement an early strategy until consolidation. Your opportunity to access experienced management in a capital efficient and flexible way to get your business off the ground.
  • 3. Biotech and medtech consultants for venture funds, industry and tech transfer offices. Track Record Truly international. Working experience based in the USA, Germany, the UK and Spain, with a truly international approach. Managed multinational teams of experts. Real world experience. Lead launch strategy for multiple new products globally. Integrate technology, IP, clinical development, CMC, regulatory, PRA & marketing. Business Development. Closed licensing deals of up to $300mn. Out-licensing and in-licensing experience. Pipeline prioritization. Target product profiling, valuation and risk assessment. Consulting expertise. More than 30 products analyzed to date in biotech and medtech, for multinationals, startups and tech transfer offices. Focus on disruptive innovation technologies. Broad professional network. Broad national and international network of investors and professionals in the sector. Raised over €30 million in venture capital in the past. Partnerships We are the lifescience advisors for the IESE Business Angels & Family Office Network. We have an exclusivity agreement with ONE to ONE as Lifescience Industry Experts with access to all their corporate finance expertise. We act as business advisors for m+vision, the consortium between the MIT and the Madrid Region to support joint innovation in medical devices. We collaborate with TTS Ltd in creating and developing outstanding international tech transfer events, like the TTS Biomedtech 2013. We are members of the Biospain’s Investment Jury, to help them evaluate new biomedical technologies.
  • 4. Biotech and medtech consultants for venture funds, industry and tech transfer offices. Examples of technologies analyzed to date Pharma/Biotech Advanced Therapies Medical Devices PDE5 inhibitor for treatment of Dendritic cell autologous Multiparametric microchip for pulmonary arterial vaccines loaded with tumor detection of biofilms in hypertension. antigen for cancer treatment. implanted catheters. Estrogen receptor β for Cultured autologous Impedimetric sensor device for treatment of BPH. melanocytes on a nanofiber endotoxin detection. scaffold for vitiligo treatment. ADP receptor inhibitor for Flat electrode arrays for treatment of acute coronary Biodegradable nanofiber cochlear implant atraumatic syndrome. polymer for direct surgery. chemotherapy delivery in PDE5 inhibitor for treatment of glioblastoma treatment . Interactive real-time platform benign prostatic hyperplasia. for biological soft tissue LSCD corneal regeneration with mechanical behaviour RNA‐sequencing biomarkers for simulation. limbal tissue cultured on cancer diagnosis and prognosis. polymeric scaffolds. Magnetic resonance DNA marker-based kit to predict Biodegradable drug eluting elastography system to improve rectal cancer response to stents with nanofiber polymers. brain imaging. neoadjuvant RCT. Robotic computer assisted Wound healing nanofiber PDE5 inhibitor for treatment of surgery for transpedicular spine bandages with drug delivery Peyronie’s disease. fixation. technology. WRAPUP©. Our proprietary product assessment approach Relevant Is there a real unmet need for your tech today? Profitable Unique How profitable and cashable is it? Will it stay competitive in the future? What Achievable Protectable What risks & barriers may prevent success? Can it be protected from copyists?
  • 5. www.dynomicsbmt.com Now follow us at: